Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,196 | -6,272 | -6,959 | -1,929 | N/A |
| Depreciation Amortization | 66 | 51 | 46 | 38 | N/A |
| Accounts receivable | -122 | -13 | N/A | N/A | N/A |
| Other Working Capital | -818 | 770 | -505 | 488 | N/A |
| Other Operating Activity | 1,544 | 1,385 | 4,207 | 91 | 0 |
| Operating Cash Flow | $-5,525 | $-4,080 | $-3,211 | $-1,312 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -113 | -41 | -129 | -12 | N/A |
| Purchase Of Investment | -322 | -339 | -60 | N/A | N/A |
| Investing Cash Flow | $-435 | $-380 | $-189 | $-12 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2,374 | N/A |
| Debt Repayment | N/A | N/A | -42 | -85 | N/A |
| Common Stock Issued | 5,496 | 30 | 7,071 | N/A | N/A |
| Other Financing Activity | 407 | 1,846 | -1,093 | 0 | 0 |
| Financing Cash Flow | $5,903 | $1,876 | $5,936 | $2,289 | $N/A |
| Beginning Cash Position | 950 | 3,535 | 999 | 34 | N/A |
| End Cash Position | 893 | 950 | 3,535 | 999 | N/A |
| Net Cash Flow | $-57 | $-2,584 | $2,536 | $965 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,525 | -4,080 | -3,211 | -1,312 | N/A |
| Capital Expenditure | -113 | -41 | -129 | -12 | N/A |
| Free Cash Flow | -5,638 | -4,121 | -3,341 | -1,325 | 0 |